![]() |
市场调查报告书
商品编码
1859796
全球荷尔蒙平衡补充市场:预测(至2032年)-按成分类型、产品形式、消费者群体、通路和地区分類的分析Hormonal Balance Supplements Market Forecasts to 2032 - Global Analysis By Ingredient Type, Product Form, Consumer Group, Distribution Channel, and By Geography |
||||||
据 Stratistics MRC 称,全球荷尔蒙平衡补充剂市场预计到 2025 年将达到 38 亿美元,到 2032 年将达到 67 亿美元,预测期内复合年增长率为 8.1%。
荷尔蒙平衡补充剂采用植物萃取物、适应原、维生素、矿物质和临床研究的化合物配製而成,旨在支持内分泌功能、生殖健康、压力反应和代谢调节。目标消费者寻求一种无需处方笺、以生活方式为导向的症状管理和长期健康维护方法。市场扩张的驱动因素包括健康意识的提高、人口结构的变化以及内分泌问题筛检的增加。
据梅奥诊所称,消费者使用包括植物雌激素产品在内的荷尔蒙平衡补充剂的情况正在增加,美国有 11% 的成年女性表示正在使用补充剂来缓解更年期症状或补充荷尔蒙。
人们对荷尔蒙健康的认识不断提高
荷尔蒙健康意识的提升:大众对荷尔蒙健康的日益关注推动了对调节月经平衡、缓解更年期症状、支持甲状腺功能和改善肾上腺疲劳等保健品的需求。受社群媒体、意见领袖和便利健康资讯的影响,消费者正在寻求预防和治疗方案。医疗保健专业人员推荐针对性膳食补充剂,而配方师则致力于开发基于实证医学的配方和个人化剂量方案。零售通路的拓展、订阅模式的改进以及更清晰的标籤标识提高了产品的可及性和可信度,而临床研究和品质保证体系的完善则极大地增强了消费者的信心,从而支撑了不同人群和分销渠道的市场稳步增长。
缺乏强而有力的临床证据
缺乏强有力的临床证据:由于缺乏严格的临床试验和标准化的剂量指南,医疗保健专业人员对荷尔蒙补充剂的推荐以及医疗机构的采购受到限制。许多产品依赖传统用法和小规模研究,导致其在不同族群中的疗效和安全性存在不确定性。这些科学上的不足阻碍了保险覆盖和大规模临床应用,而监管机构则要求更高的证据标准。因此,消费者的怀疑态度和零售商谨慎的商品上架做法减缓了市场渗透率。
进军男性健康领域
进军男性健康领域:针对男性荷尔蒙健康,市场前景广阔,能够有效解决男性对睪固酮平衡、性慾和老龄化相关代谢等方面的担忧。随着越来越多的男性寻求预防性健康产品和个人化方案,该领域正在不断扩张。针对男性生理特征的临床讯息、隐藏的行销管道以及胶囊和软糖等男性专用配方,正在提升市场接受度。与泌尿系统、健身专家以及职场健康计画的伙伴关係,能够有效推动产品普及。此外,公众意识的提高和人口结构的变化也将推动长期需求成长,并实现收入来源多元化。
仿冒品品
仿冒品伪劣产品:仿冒品、掺假或不合格保健品的氾滥,损害了合法市场的发展,削弱了消费者的信任,并带来健康风险。低劣的成分、错误标示和不一致的生产流程都可能导致不利事件、产品召回和法律诉讼,从而损害品牌声誉。零售商可能会收紧产品上架标准,监管机构也可能加强监管,增加合规成本。
疫情期间,消费者寻求增强免疫力和缓解压力,导致保健品需求激增,激素类保健品销售一度飙升。供应链中断造成短期原料短缺,并促使筹资策略转变,同时,供应中断也推动了电商和直销模式的发展。临床研究放缓,但人们对预防性保健的关注度却有所提升,促使生产者更加重视安全性和透明的标籤。整体而言,新冠疫情加速了数位化销售管道的发展,并提升了消费者对整体健康和增强自身韧性的关注。
预计在预测期内,维生素和矿物质细分市场将成为最大的细分市场。
由于消费者对其安全性的信任以及对微量营养素在甲状腺、肾上腺和生殖功能中作用的认识,预计维生素和矿物质补充剂在预测期内将占据最大的市场份额。处方医生和药剂师通常推荐这些补充剂,而且它们在包括药局、超级市场和电商在内的各种零售管道均有销售,从而推动了高销售量。低廉的单位成本、成熟的生产能力和简单的服用方法促进了重复购买。因此,预计该细分市场将保持其市场领先地位,而製造商正透过有针对性的配方和教育宣传活动来推动其普及。
预计在预测期内,软糖细分市场将实现最高的复合年增长率。
由于口感好、服用方便,软糖品类预计将在预测期内达到最高成长率,吸引年轻消费者和不愿服用药丸的人。洁净标示、无糖和质地丰富的配方提高了消费者的接受度,增加了重复购买率,同时也有助于坚持服用补充剂。醒目的口味和包装提升了软糖在零售店和线上的知名度。製造商们还推出了添加了维生素和植物成分的功能性软糖,用于支持荷尔蒙平衡。这些优势的综合作用将推动软糖品类的市场渗透,并带来较高的复合年增长率。
预计北美在预测期内将占据最大的市场份额,这主要得益于其先进的医疗保健基础设施、消费者在健康方面的高支出以及高效营养补充剂的广泛应用。丰富的零售和电商通路确保了产品的可近性,而监管则有助于提升产品品质和消费者信任度。临床医生的推荐和行销正在推动荷尔蒙补充剂的普及。领先的本土生产商正加大研发投入并建立分销伙伴关係,从而推出新的配方并扩大生产规模。这些因素共同作用,将助力北美在整个预测期内保持领先的市场份额。
预计亚太地区在预测期内将实现最高的复合年增长率,这主要得益于健康意识的提高、中等收入阶层收入的增长以及电子商务的普及,使得营养补充剂更容易获得。本土品牌和新兴企业正在研发价格亲民且符合当地文化的产品配方,而智慧型主导行销则推动了消费者的试用和重复购买。政府营养计划和不断完善的分销网络进一步促进了都市化人口的消费。这些人口、经济和数位化因素的共同作用,正在推动亚太地区营养补充剂的快速普及。
According to Stratistics MRC, the Global Hormonal Balance Supplements Market is accounted for $3.8 billion in 2025 and is expected to reach $6.7 billion by 2032, growing at a CAGR of 8.1% during the forecast period. Hormonal balance supplements formulate botanicals, adaptogens, vitamins, minerals, and clinically researched compounds to support endocrine function, reproductive health, stress response, and metabolic regulation. Target consumers seek non-prescription, lifestyle-oriented approaches to symptom management and long-term wellness. Market expansion is driven by growing health awareness, demographic shifts, and broader screening for endocrine issues.
According to Mayo Clinic, consumer use of hormonal balance supplements such as phytoestrogen products has grown, with surveys indicating that 11% of adult women in the U.S. have used supplements for menopause or hormonal support.
Growing Awareness of Hormonal Health
Growing Awareness of Hormonal Health Growing public focus on hormonal wellbeing has driven demand for supplements addressing menstrual balance, menopause, thyroid support, and adrenal fatigue. Consumers seek preventive and corrective solutions, influenced by social media, influencers, and accessible health information. Medical practitioners increasingly suggest targeted nutraceuticals as adjuncts, while formulators develop evidence-informed blends and personalised dosages. Retail expansion, subscription models, and clearer labeling improve accessibility and trust, supporting steady market growth across demographics and distribution channels, with clinical research and quality assurance driving consumer confidence widely.
Lack of Strong Clinical Evidence
Lack of Strong Clinical Evidence Insufficient rigorous clinical trials and standardized dosage guidelines limit healthcare practitioner endorsement and institutional procurement of hormonal supplements. Many products rely on traditional uses or small-scale studies, creating ambiguity about effectiveness and safety across populations. This scientific gap hampers insurance coverage and large-scale clinical adoption, while regulators demand higher evidence standards. Consequently, consumer skepticism and cautious retailer listing slow market penetration.
Expansion into Men's Health
Expansion into Men's Health Targeting male hormonal health presents a significant growth avenue, addressing testosterone balance, libido, and age-related metabolic concerns. The category is broadening as men increasingly seek preventive wellness products and personalised regimens. Clinical messaging tailored to male physiology, discreet marketing channels, and male-oriented formulations such as capsules and gummies improve market receptivity. Partnerships with urologists and fitness professionals, along with workplace wellness programs, can drive adoption. Furthermore, rising awareness and demographic shifts amplify long-term demand and diversify revenue streams.
Counterfeit and Low-Quality Products
Counterfeit and Low-Quality Products Proliferation of counterfeit, adulterated, or substandard supplements undermines consumer trust and poses health risks, eroding legitimate market growth. Low-quality ingredients, mislabeling, and inconsistent manufacturing practices can lead to adverse events, product recalls, and legal actions that damage brand reputations. Retailers may tighten listing standards, and regulators may impose stricter oversight, increasing compliance costs.
The pandemic spurred rapid consumer adoption of supplements as people sought immune support and stress management, temporarily boosting sales across hormonal supplement categories. Supply chain disruptions caused short-term ingredient shortages and shifted sourcing strategies, while lockdowns encouraged ecommerce and direct-to-consumer models. Clinical research slowed but interest in preventive health rose, prompting manufacturers to emphasise safety and transparent labeling. Overall, COVID-19 accelerated digital sales channels and heightened consumer focus on holistic wellbeing and resilience.
The vitamins & minerals segment is expected to be the largest during the forecast period
The vitamins & minerals segment is expected to account for the largest market share during the forecast period because consumers trust their safety and recognise micronutrients' role in thyroid, adrenal, and reproductive function. Prescribers and pharmacists commonly recommend these supplements, and broad retail availability across pharmacies, supermarkets, and ecommerce drives high volumes. Low unit costs, established manufacturing capacity, and simple dosing encourage repeat purchases. Consequently, this segment sustains market leadership while enabling manufacturers to create targeted combination formulas and educational campaigns that boost adoption.
The gummies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the gummies segment is predicted to witness the highest growth rate due to taste and ease of use, attracting younger consumers and pill-averse buyers. Clean-label, sugar-free, and textured formulations improve acceptability while supporting adherence to supplement regimens, increasing repeat purchases. Eye-catching flavours and packaging boost retail and online visibility. Manufacturers also launch functional gummy blends that combine vitamins and botanicals for hormonal support. Collectively, these advantages accelerate market penetration and result in higher compound annual growth rates for gummy formats.
During the forecast period, the North America region is expected to hold the largest market share owing to advanced healthcare infrastructure, high consumer spending on wellness, and strong supplement penetration. Broad retail and ecommerce channels ensure access, while regulatory oversight fosters product quality and consumer confidence. Clinician recommendations and marketing drive adoption of hormonal supplements. Large domestic manufacturers invest in R&D and form distribution partnerships, enabling new formulations and scale. These combined factors sustain North America's leading market share through the forecast period.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to rising health awareness, growing middle-class incomes, and expanding ecommerce penetration that makes supplements widely accessible. Local brands and startups produce affordable, culturally relevant formulations, while smartphone-driven marketing accelerates trial and repeat purchases. Government nutrition programmes and improving distribution networks further support uptake across urbanising populations. Combined, these demographic, economic, and digital factors create a faster adoption curve in Asia Pacific
Key players in the market
Some of the key players in Hormonal Balance Supplements Market include Nature's Bounty Co., NOW Foods, Inc., Thorne Research, Inc., Garden of Life, LLC, Life Extension Foundation, Inc., Swanson Health Products, Inc., Herbalife Nutrition Ltd., Amway Corporation, GNC Holdings, LLC, Jarrow Formulas, Inc., Pure Encapsulations, LLC, MegaFood, LLC, Integrative Therapeutics, LLC, Himalaya Wellness Company, USANA Health Sciences, Inc., and Suntory Holdings Limited.
In June 2025, Nature's Bounty Co. launched "Advanced Menopause Relief", a plant-based, hormone-free dietary supplement designed for women in all stages of menopause. The product claims to help balance hormones and ease symptoms such as hot flashes, night sweats, low energy, anxiety and mood swings in one daily tablet.
In March 2025, Nature's Bounty shared new survey data showing that symptoms of menopause persist for many women and used this insight to support their product development in women's wellness and hormone-balance supplementation.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.